InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2023-05-11 00:00:00 ET · period of report 2023-05-10 · accession 0001225208-23-005755 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-05-11 2023-05-10 EW Ullem Scott B. CFO, CVP S - Sale+OE $88.54 -80.7K 18.3K -82% -$7.14M
D 2023-05-11 2023-05-10 EW Ullem Scott B. CFO, CVP M - OptEx $35.20 +80.7K 99.0K +441% +$2.84M
D 2023-05-11 2023-05-10 EW Ullem Scott B. CFO, CVP M - OptEx $0.00 -80.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-10 S D 16,581 $89.22 82,413 D — — (F2) This transaction was executed in multiple trades at prices ranging from $88.89 to $89.44 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2023-05-10 M A 80,700 $35.20 98,994 D — —
3 Common Common Stock 2023-05-10 S D 64,119 $88.36 18,294 D — — (F3) This transaction was executed in multiple trades at prices ranging from $87.89 to $88.88 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2023-05-10 M D 80,700 $0.00 0 D $35.20 · 2017-05-12 to 2023-05-11 80,700 Common Stock